ANTIVIRAL CHEMOTHERAPY - MECHANISM OF ACT ION, ACTIVITY EVALUATION, RESISTANCE AND FURTHER DEVELOPMENTS

Citation
H. Agut et al., ANTIVIRAL CHEMOTHERAPY - MECHANISM OF ACT ION, ACTIVITY EVALUATION, RESISTANCE AND FURTHER DEVELOPMENTS, Pathologie et biologie, 41(8BIS), 1993, pp. 770-776
Citations number
22
Categorie Soggetti
Pathology
Journal title
ISSN journal
03698114
Volume
41
Issue
8BIS
Year of publication
1993
Pages
770 - 776
Database
ISI
SICI code
0369-8114(1993)41:8BIS<770:AC-MOA>2.0.ZU;2-M
Abstract
Antiviral chemotherapy is based on the selective inhibition of intrace llular virus multiplication. Inhibitors of viral DNA polymerases perfe ctly exemplifies this mode of action. In spite of their selectivity, s ome of these drugs are cytotoxic and all remain unefficient against la tent viruses. Evaluation of antiviral activity requires in vitro sensi tivity tests, in vivo studies on animals and virological analyses duri ng clinical trials. This evaluation needs well standardized assays. Th e emergence of in vitro resistance reflects the occurrence of mutation s regarding target enzymes. Clinical significance of antiviral drug re sistance needs to be assessed in many circumstances, even if its assoc iation with immunodeficiency often leads to a clear therapeutic failur e. Further developments will include the synthesis of novel inhibitors , study of drug associations and improvement of virological diagnosis techniques relevant to therapy.